Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer
Luis D. Borrero-García(University of Puerto Rico, Medical Sciences Campus), Suranganie Dharmawardhane(University of Puerto Rico, Medical Sciences Campus)
Cited by 20
Related Papers
Individual and combined soy isoflavones exert differential effects on metastatic cancer progression
|Clinical & Experimental Metastasis|2010|68
Dietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice
|BMC Complementary and Alternative Medicine|2013|40
Efficacy and delivery strategies of the dual Rac/Cdc42 inhibitor MBQ-167 in HER2 overexpressing breast cancer
|Translational Oncology|2024|5